Dr. Opyrchal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1030 W Michigan St
Indianapolis, IN 46202Phone+1 888-600-4822- Is this information wrong?
Summary
- Dr. Mateusz Opyrchal is an oncologist in Indianapolis IN and is affiliated with Simon Cancer Center. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 10 years. He also speaks multiple languages, including Polish. He specializes in breast cancer and experimental theuraputics and is experienced in immunotherapy, cellular therapy, breast cancer, melanoma, and combined modality therapy.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2010 - 2013
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2007 - 2010
- Rutgers New Jersey Medical SchoolClass of 2007
Certifications & Licensure
- IN State Medical License 2021 - 2025
- IL State Medical License 2019 - 2023
- MO State Medical License 2019 - 2022
- NY State Medical License 2013 - 2021
- MN State Medical License 2008 - 2014
Awards, Honors, & Recognition
- Golden Apple Teaching Award 2016
- Promising Young Investigator Award University of Buffalo Medicine Department, 2015
Clinical Trials
- Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer Start of enrollment: 2018 Feb 19
- T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer Start of enrollment: 2018 Dec 06
- Evaluate Eribulin ORA in Subjects With Solid Tumors Start of enrollment: 2019 Jul 29
Publications & Presentations
PubMed
- Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression.Tzetzo, S., Kramer, E., Mohammadpour, H., Kim, M., Rosario, S., Yu, H., Dolan, M., Oturkar, C., Morreale, B., Bogner, P., Stablewski, A., Benavides, F., Brackett, C., ...> ;Iscience. 2024 Mar 15
- A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.Cinta Hierro, Jordi Rodon, Andreas Wicki, Martin D Forster, Sarah P Blagden, Jun Yin, Joel M Reid, Helene Muller, Natasa Cmiljanovic, Vladimir Cmiljanovic, Filip Janku...> ;Cancers. 2024 Mar 13
- A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.Dejan Juric, Minal Barve, Ulka Vaishampayan, Desamparados Roda, Aitana Calvo, Noelia Martinez Jañez, Jose Trigo, Alastair Greystoke, R Donald Harvey, Anthony J Olszans...> ;Cancer Medicine. 2024 Mar 1
- Join now to see all
Press Mentions
- April 20 - Vera Bradley Foundation for Breast Cancer Donates $12.5M to the Indiana University School of MedicineApril 20th, 2022
- Hemispherx Biopharma Issues Clinical Update for Ampligen Immuno-Oncology ProgramJune 17th, 2019
- New Clinical Trials at Roswell Park Build on Virus Research for Innovative Immunotherapy ApproachJanuary 3rd, 2019
- Join now to see all
Grant Support
- Predictive Markers of Response in Ph II Axitinib in MelanomaNCCN/Pfizer (PI)2011–2018
Committees
- Member, Medication Orders Subcommittee 2018 - 2019
- Member, Health Informatics Committee 2018 - 2019
- Member, IND SAE Trending Committee 2017 - 2019
- Member, Clinical Research IT Governance Committee 2017 - 2019
- Member, Chief of Off-Label Committee 2017 - 2019
- Member, GYN Molecular Tumor Path Conference 2016 - 2019
- Member, Scientific Advisory Committee (SAC) 2016 - 2019
- Member, Pharmacy & Therapeutic Committee (P & T) 2015 - 2019
- Member, Scientific Review Committee (SRC) 2014 - 2019
Professional Memberships
- American Association for Cancer Research (AACR)Member
- Member
- Member
Other Languages
- Polish
Hospital Affiliations
- Indiana University Health West HospitalAvon, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: